UNSPSC 51282803: Ornidazole

This classification denotes an amebicide, antitrichomonal agent, and radiation-sensitizing agent with the molecular formula C7H10ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62XCK0G93T, chemically known as 1h-imidazole-1-ethanol, alpha-(chloromethyl)-2-methyl-5-nitro- but generally known as ornidazole, which bears US NIH Compound Identifier 28061. European Medicines Agency schedules Ornidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09464MIG.

UNSPSC 51282803 Ornidazole is a Commodity code nominally assigned to a single pharmaceutical product, but the recent state and local opportunities tagged under it show minimal direct alignment with ornidazole procurement itself. Instead, the code appears in solicitations for broader medical and pharmaceutical supply categories, including emergency medical supplies, generic multi-source pharmaceuticals, over-the-counter products, and naloxone-based drug response systems. State and local issuing bodies pursuing opportunities under this code include county health departments, state health and human services agencies, municipal fire departments, and cooperative purchasing alliances spanning multiple states. The work actually being solicited ranges from emergency medical consumables for first responder use through comprehensive pharmaceutical supply agreements with manufacturers and wholesalers serving state employee health plans and public health agencies.

Recent activity spans multiple jurisdictions and procurement instruments. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, with quarterly deliveries and fixed-fee pricing. The City of Tampa Purchasing Department posted IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a sheltered-market set-aside for certified Small Local Business Enterprises and a 5 percent SLBE bid discount. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, requiring vendors to work through three authorized wholesalers and submit detailed NDC, SKU, and UPC data. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program. Geographic spread includes Florida, Texas, and the Minnesota-Oregon cooperative network, with procurement activity concentrated in health departments, fire services, and state employee health benefit programs.